Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MAIA
#4081
MAIA Biotechnology, Inc.
1.470
0
USD
+6.14%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+6.14%
Monthly Change
-3.29%
6 month change
-29.33%
Year Change
-29.33%
Previous Close
1.385
0
Open
1.425
0
Bid
Ask
Low
1.420
0
High
1.470
0
Volume
67
Markets
US Stock Market
Healthcare
MAIA
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11 M
20 M
29.59 M
60.67 M
—
Valuation ratios
Enterprise value
38.93 M
23.8 M
58.58 M
92.83 M
255.62 M
Price to earnings ratio
-2.02
-0.8
-1.89
-2.19
-9.85
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
-2.82
-1.21
-2.8
-2.61
-10.48
Price to book ratio
3.75
6
6.95
20.68
28.28
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-1.31
-2.61
-2.29
-2.31
-1.99
Return on equity %
-1.85
-41.41
-6.4
-9.43
-217.48
Return on invested capital %
-683.08
-1 124.73
-1 202.81
-1 904.89
-2 225.27
Gross margin %
—
—
—
—
—
Operating margin %
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
3.61
1.53
2.65
1.66
7.37
Inventory turnover
—
—
—
—
—
Asset turnover
0
0
0
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.26
-0.99
-0.71
-0.59
-0.61
EBIT per share
-1.74
-1.52
-0.76
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
0
0
0
0
0
Net current asset value per share
1.27
0.57
0.46
0.3
1.45
Tangible book value per share
0.94
0.2
0.28
0.07
0.38
Working capital per share
0.92
0.2
0.28
0.12
0.62
Book value per share
0.94
0.2
0.28
0.07
0.38
MAIA Biotechnology Inc
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.
News
MAIA Biotechnology shares drop 29% on discounted stock offering
Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares
Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares
Maia Biotech CEO Vitoc Vlad buys $10k in company stock
MAIA Biotechnology raises $736,600 in private placement
Maia Biotechnology to issue 440,503 shares after warrant exercise at reduced price
Maia Biotechnology presents Phase 2 THIO-101 trial data at lung cancer conference
Maia Biotechnology stock soars after FDA grants Fast Track designation